SVB Leerink analyst Joseph Schwartz downgraded ChemoCentryx (NASDAQ: CCXI) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

ChemoCentryx (CCXI) Crashes 55% on Mixed AdComm Results, Gets Downgraded at Five FirmsMay 7, 2021 9:36 AM Raymond James Downgrades ChemoCentryx (CCXI) to OutperformMay 7, 2021 7:38 AM ChemoCentryx (CCXI) sinks 45% as trading resumes following mixed FDA AdComMay 7, 2021 7:15 AM